BioSpace News Archive

First Clinical Data from Phase 1 Trial of SY-1365 in Advanced Solid Tumors to be Highlighted in Oral Plenary Session

The Company developed a new recombinant spider silk fiber with properties targeted for protective textile applications

IND to be submitted early 2019, with phase 2a clinical trial initiation following IND acceptance

Study finds specific subset of patients face extremely low risk of cancer returning even without additional treatment

Rigel Pharmaceuticals, Inc. today announced that it will report its third quarter 2018 financial results after market close on Tuesday, November 6, 2018.

Aerie Pharmaceuticals, Inc. announced today that its third quarter 2018 financial results will be released after the market closes on Tuesday, November 6, 2018.

One of the top global diabetes apps now spots recurring high or low patterns and automatically notifies users so they can take action to avoid them in the future

Tivity Health, Inc. (NASDAQ: TVTY) will present at the 27th Annual Credit Suisse Healthcare Conference to be held November 12-15, 2018 in Scottsdale, AZ. Donato Tramuto, Tivity Health’s chief executive officer, will present at the conference at 9:45 a.m. MT (11:45 p.m. ET and 8:50 a.m. PT), Tuesday, November 13, 2018.

LandStar, Inc. will be offering a Personal Privacy Compliance service to support the medical marijuana industry anticipated to reach $8 billion in annual sales in the United States by 2024.

Halozyme Therapeutics, Inc. today announced that it has licensed its ENHANZE® drug-delivery technology to Roche for exclusive development of a new undisclosed clinical stage therapeutic target, with an option to select two additional targets within four years.